TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder that affects more than 37 million people worldwide. Current drugs for AD are only symptomatic, but do not interfere with the underlying pathogenic mechanisms of the disease. AD is characterized by the presence of ß‐amyloid (Aβ) plaques, n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Caraci, Filippo, Battaglia, Giuseppe, Bruno, Valeria, Bosco, Paolo, Carbonaro, Viviana, Giuffrida, Maria Laura, Drago, Filippo, Sortino, Maria Angela, Nicoletti, Ferdinando, Copani, Agata
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2009
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493850/
https://ncbi.nlm.nih.gov/pubmed/19925479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00115.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados